|
CCDC85C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.642200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.723200E-01 |
| Normal-vs-Stage2 |
5.417100E-03 |
| Normal-vs-Stage3 |
6.342400E-01 |
| Normal-vs-Stage4 |
7.136000E-01 |
| Stage1-vs-Stage2 |
8.772100E-04 |
| Stage1-vs-Stage3 |
6.234000E-01 |
| Stage1-vs-Stage4 |
5.526400E-01 |
| Stage2-vs-Stage3 |
1.354500E-02 |
| Stage2-vs-Stage4 |
3.539200E-03 |
| Stage3-vs-Stage4 |
4.106000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.779400E-01 |
| Normal-vs-AfricanAmerican |
7.786400E-01 |
| Normal-vs-Asian |
7.097000E-01 |
| Caucasian-vs-AfricanAmerican |
9.896400E-01 |
| Caucasian-vs-Asian |
9.886800E-01 |
| AfricanAmerican-vs-Asian |
9.854000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.440600E-01 |
| Normal-vs-Female |
6.704800E-01 |
| Male-vs-Female |
4.428600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.075000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.525800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.860600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.196000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.968300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.948800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.606600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.276600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.059600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.184800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.704400E-02 |
| Classical-VS-Follicular |
4.417800E-01 |
| Classical-VS-Other |
7.274200E-01 |
| Classical-VS-Normal |
4.187400E-01 |
| Tall-VS-Follicular |
4.709600E-02 |
| Tall-VS-Other |
5.407400E-01 |
| Tall-VS-Normal |
2.510800E-01 |
| Follicular-VS-Other |
5.913400E-01 |
| Follicular-VS-Normal |
2.002000E-01 |
| Other-VS-Normal |
9.859800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.901200E-01 |
| Normal-vs-N1 |
7.953700E-02 |
| N0-vs-N1 |
2.461700E-03 |
|
|
